Home › Compare › HKMPY vs MCD

HKMPY vs MCD: Dividend Comparison 2026

HKMPY yields 4.73% · MCD yields 2.34%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 HKMPY wins by $134.01M in total portfolio value
10 years
HKMPY
HKMPY
● Live price
4.73%
Share price
$35.06
Annual div
$1.66
5Y div CAGR
82%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$134.08M
Annual income
$121,431,071.65
Full HKMPY calculator →
MCD
McDonald's Corporation
● Live price
2.34%
Share price
$310.79
Annual div
$7.26
5Y div CAGR
42.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$77.7K
Annual income
$25,833.37
Full MCD calculator →

Portfolio growth — HKMPY vs MCD

📍 HKMPY pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodHKMPYMCD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, HKMPY + MCD cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
HKMPY pays
MCD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

HKMPY
Annual income on $10K today (after 15% tax)
$402.45/yr
After 10yr DRIP, annual income (after tax)
$103,216,410.90/yr
MCD
Annual income on $10K today (after 15% tax)
$198.56/yr
After 10yr DRIP, annual income (after tax)
$21,958.36/yr
At 15% tax rate, HKMPY beats the other by $103,194,452.54/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of HKMPY + MCD for your $10,000?

HKMPY: 50%MCD: 50%
100% MCD50/50100% HKMPY
Portfolio after 10yr
$67.08M
Annual income
$60,728,452.52/yr
Blended yield
90.53%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MCD right now

HKMPY
No analyst data
Altman Z
3.5
Piotroski
7/9
MCD
Analyst Ratings
37
Buy
23
Hold
1
Sell
Consensus: Buy
Price Target
$351.76
+13.2% upside vs current
Range: $320.00 — $385.00
Altman Z
4.9
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

HKMPY buys
0
MCD buys
0
No recent congressional trades found for HKMPY or MCD in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricHKMPYMCD
Forward yield4.73% ✓2.34%
Annual dividend / share$1.66$7.26 ✓
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR82% ✓42.3%
Portfolio after 10y$134.08M ✓$77.7K
Annual income after 10y$121,431,071.65 ✓$25,833.37
Total dividends collected$133.09M ✓$57.7K
Payment frequencyquarterlyquarterly
SectorStockConsumer Discretionary

Year-by-year: HKMPY vs MCD ($10,000, DRIP)

YearHKMPY PortfolioHKMPY Income/yrMCD PortfolioMCD Income/yrGap
1← crossover$11,562$861.72$10,812$332.41+$750.00 → HKMPY
2$14,066$1,694.64$11,819$488.02+$2.2K → HKMPY
3$18,557$3,506.74$13,111$724.37+$5.4K → HKMPY
4$27,725$7,869.35$14,832$1,091.05+$12.9K → HKMPY
5$49,665$19,998.40$17,219$1,675.85+$32.4K → HKMPY
6$114,074$60,932.92$20,688$2,641.85+$93.4K → HKMPY
7$360,116$238,056.37$25,990$4,309.70+$334.1K → HKMPY
8$1,663,594$1,278,270.23$34,590$7,351.77+$1.63M → HKMPY
9$11,824,255$10,044,209.16$49,535$13,285.25+$11.77M → HKMPY
10$134,083,024$121,431,071.65$77,746$25,833.37+$134.01M → HKMPY

HKMPY vs MCD: Complete Analysis 2026

HKMPY — Stock

Hikma Pharmaceuticals PLC develops, manufactures, markets, and sells a range of generic, branded, and in-licensed pharmaceutical products. The company offers its products in solid, semi-solid, liquid, and injectable final dosage forms. It operates through three segments: Injectables, Generics, and Branded. The Injectables segment provides generic injectable products primarily for use in hospitals. The Generics segment offers oral and other non-injectable generic products for the retail market. The Branded segment offers branded generics and in-licensed products to retail and hospital markets. The company provides its products in various therapeutic areas, including anti-infective, cardiovascular, central nervous system, diabetes, oncology, pain management, and respiratory. It operates in the United Kingdom, the United States, the Middle East, North Africa, Europe, and internationally. The company was founded in 1978 and is based in London, the United Kingdom.

Full HKMPY Calculator →

MCD — Consumer Discretionary

McDonald's Corporation operates and franchises McDonald's restaurants in the United States and internationally. Its restaurants offer hamburgers and cheeseburgers, chicken sandwiches and nuggets, wraps, fries, salads, oatmeal, shakes, desserts, sundaes, soft serve cones, bakery items, soft drinks, coffee, and beverages and other beverages, as well as breakfast menu, including biscuit and bagel sandwiches, breakfast burritos, hotcakes, and other sandwiches. As of December 31, 2021, the company operated 40,031 restaurants. McDonald's Corporation was founded in 1940 and is headquartered in Chicago, Illinois.

Full MCD Calculator →
📬

Get this HKMPY vs MCD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

HKMPY vs SCHDHKMPY vs JEPIHKMPY vs OHKMPY vs KOHKMPY vs MAINHKMPY vs YUMHKMPY vs QSRHKMPY vs SBUX

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.